Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Will Continuous Manufacturing Mean Continuous Generic Delay? FDA Hears AAM's Warning
Dec 04 2017
•
By
Bowman Cox
The future may be continuous -- and then back to batch
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance